ArticleCureus2024
Impact of a Single Session of Hybrid Carbon Dioxide 10600 Nanometer and 1540 Nanometer Laser With Platelet-Rich Plasma Treatment in the Genital Area to Treat Female Sexual Dysfunction: A Pilot Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Female sexual dysfunction (FSD) affects a significant portion of the female population, negatively impacting quality of life. New therapeutic approaches, such as the combination of laser therapy and platelet-rich plasma (PRP), are being explored as potential treatments to enhance sexual function in affected women. Methods This original study involved 23 women aged 37 to 72, all diagnosed with varying degrees of FSD (mild, moderate, severe). The participants underwent a pre-treatment evaluation using a custom-designed Likert scale (Female Sexual Health Questionnaire) designed by the authors to evaluate the symptoms of the patients. The treatment involved a single session combining hybrid carbon dioxide 10600 nm and 1540 nm laser therapy with PRP applied to the genital area. One month post-treatment, participants were reassessed using the same questionnaire. Results Of the 23 patients studied, 65.2% (15 patients) exhibited hypoactive sexual desire, and 73.33% of them (11 out of 15) demonstrated improvement post-treatment (P = 0.00048). Overall sexual satisfaction increased by 28.2% (P = 0.0032), and lubrication improved in 54.5% of patients (P = 0.0027). Significant reductions in dyspareunia were observed, with 80% of patients experiencing pain relief (P = 0.0035). Patients with moderate dysfunction showed the highest response, with 100% (6 out of 6) demonstrating improvement across domains (P = 0.0009). Postmenopausal women experienced a 30.9% improvement in sexual function (P = 0.007), while premenopausal women exhibited a 7.5% improvement (P = 0.04). Statistically significant changes were also noted in the frequency of orgasm (P = 0.0058) and genital sensitivity in patients with moderate dysfunction. Conclusion Our data indicated significant improvements in FSD, particularly in moderate to severe dysfunction, with positive changes in key aspects of sexual function such as lubrication, desire, and ease of orgasm. However, the limited number of participants and short follow-up in this pilot study highlight the need for further investigation into hybrid CO2/1540 nm laser therapy combined with PRP as a therapeutic option for female sexual dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.